VJHemOnc is committed to improving our service to you

EHA 2019 | Myelofibrosis: unmet needs

VJHemOnc is committed to improving our service to you

Kristen Pettit

Kristen Pettit, MD, University of Michigan, Ann Arbor, MI, tells us about the pathology of myelofibrosis, the current FDA approved medication available and the unmet needs patients face. This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter